MICHAEL MORNEAU Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL MORNEAU.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL MORNEAU. MICHAEL MORNEAU is a VP Finance & CAO in Trius Therapeutics Inc ($TSRX) and a VPF and CAO in Trius Therapeutics Inc ($TSRX) and a Chief Financial Officer in Viking Therapeutics, Inc. ($VKTX) and a VP, Finance and Administration in Viking Therapeutics, Inc. ($VKTX).
Address: C/O TRIUS THERAPEUTICS, INC. 6310 NANCY RIDGE DRIVE, SUITE 101 SAN DIEGO 92121 CA
Companies in which MICHAEL MORNEAU is an Insider
Trius Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL MORNEAU: VPF and CAO, VP Finance & CAO
Holdings: 0 shares
Latest Transaction: Mar 11 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viking Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MICHAEL MORNEAU: VP, Finance and Administration, Chief Financial Officer
Holdings: 116,062 shares
Current Value: $168,290
Latest Transaction: Jan 19 2021
$VKTX Market Capitalization: $31.36M
$VKTX Previous Close: $1.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of MICHAEL MORNEAU
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 6.68 | 1,685 | 11,256 | 116,062 | 117.7 K to 116.1 K (-1.43 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Option Exercise | A | 5.80 | 33,000 | 191,400 | 33,000 | |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 5.80 | 2,739 | 15,886 | 117,747 | 120.5 K to 117.7 K (-2.27 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 6,667 | 0 | 120,486 | 113.8 K to 120.5 K (+5.86 %) |
| Jan 06 2021 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 14,667 | 0 | 113,819 | 99.2 K to 113.8 K (+14.79 %) |
| Sep 16 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Payment of Exercise | F | 6.25 | 1,557 | 9,731 | 97,873 | 99.4 K to 97.9 K (-1.57 %) |
| Sep 16 2020 | VKTX | Viking Therapeutic ... | MORNEAU MICHAEL | VP, Finance and Adm ... | Grant | A | 0.00 | 4,500 | 0 | 99,430 | 94.9 K to 99.4 K (+4.74 %) |